Evidence map›Paper›PMID 31559210›Full record

ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2019

The EBV-DNA Can be Used as a Diagnostic and Follow-up Parameter of the Rhinopharyngeal Tumors in the Non-Endemic Population of the Western Sicily.

F Lorusso, M P Caleca, C Bellavia, D Pistoia, S Gallina, R Speciale, F Dispenza, T Fasciana, G Capra

Open access · greenAbstract read
In one paragraph

Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Application of PCR and Microscopy to DetectThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2019
    Article
  5. Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-ResistantThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2019
    Article
  6. Immunization with a SyntheticThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2019
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

F Lorusso1Unit of Otolaringology, Department of Experimental Biomedicine and Clinical Neurosciences, Polyclinic University Hospital "Paolo Giaccone", University of Palermo, Via del Vespro, 133, 90127 Palermo, Italy.
M P Caleca2Department of Sciences for Health Promotion and Mother-Child Care "G. D'Alessandro", Polyclinic University Hospital "Paolo Giaccone", University of Palermo, Via del Vespro, 133, 90127 Palermo, Italy.
C Bellavia2Department of Sciences for Health Promotion and Mother-Child Care "G. D'Alessandro", Polyclinic University Hospital "Paolo Giaccone", University of Palermo, Via del Vespro, 133, 90127 Palermo, Italy.
D PistoiaPolyclinic University Hospital "Paolo Giaccone", Via del Vespro, 133, 90127 Palermo, Italy.
S Gallina1Unit of Otolaringology, Department of Experimental Biomedicine and Clinical Neurosciences, Polyclinic University Hospital "Paolo Giaccone", University of Palermo, Via del Vespro, 133, 90127 Palermo, Italy.
R Speciale1Unit of Otolaringology, Department of Experimental Biomedicine and Clinical Neurosciences, Polyclinic University Hospital "Paolo Giaccone", University of Palermo, Via del Vespro, 133, 90127 Palermo, Italy.
F Dispenza1Unit of Otolaringology, Department of Experimental Biomedicine and Clinical Neurosciences, Polyclinic University Hospital "Paolo Giaccone", University of Palermo, Via del Vespro, 133, 90127 Palermo, Italy.
T Fasciana2Department of Sciences for Health Promotion and Mother-Child Care "G. D'Alessandro", Polyclinic University Hospital "Paolo Giaccone", University of Palermo, Via del Vespro, 133, 90127 Palermo, Italy.
G Capra2Department of Sciences for Health Promotion and Mother-Child Care "G. D'Alessandro", Polyclinic University Hospital "Paolo Giaccone", University of Palermo, Via del Vespro, 133, 90127 Palermo, Italy.ORCID 0000-0002-1407-7282
Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo · ITUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To evaluate whether EBV-DNA can be used as a diagnostic and follow-up parameter for nasopharyngeal tumors in a non-endemic population. The study was carried out in a university hospital. A retrospective study was conducted on 40 paraffin samples of histological preparations. EB-DNA was detected by real-time PCR technique. A prospective study was also conducted on a group of 30 patients who underwent nasopharyngeal biopsy for suspected nasopharyngeal carcinoma (NPC) by comparing EBV-DNA concentrations between the histological specimen and the serum. Quantification of genomic copies of EBV-DNA in serum and detection of anti-EBV antibodies was performed. In both groups the presence of high viral load of EBV-DNA was found in nonkeratinizing squamous cell carcinomas, in three cases of lymphepitomyoma and in 4 out of 6 cases of non-differentiated non-carcinoma lymph node metastases. squamous keratinizing cells. In all cases of NPC, an antibody pattern typical of reactivations (IgGVCA+, IgG-EA+, IgG-EBNA+) and IgA-EA-D, frequently positive in cases of NPC, has been highlighted. A good correlation between the high EBV-DNA charges and the histological diagnosis was highlighted. Our study also found that the assessment of viral EBV load can also be considered in the prognostic evaluation and in the follow-up of patients with NPC.

Indexed as

Cancer of nasopharynxEBVNasopharyngeal carcinomaNasopharyngeal neoplasm

Identifiers

PMID31559210
PMCPMC6737200
OpenAlexW2809276023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.